论文部分内容阅读
Background:To investigate the clinical characteristics and outcome of HBV reactivation in hepatitis B surface antigen(HBsAg)-negative and hepatitis B core antibody(anti-HBc)-positive patients with hematologic malignancy after chemotherapy or hematopoietic stem cell transplantation(HSCT) in Korea.